The latest research from Fore Pharma, Europe Hypertension Market and Competitive Landscape – 2020, provides comprehensive insights into Hypertension pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Hypertension market size and drug sales. It also provides insights into Hypertension epidemiology and late stage pipeline.
This research covers the following – Hypertension treatment options, Hypertension late stage clinical trials pipeline, Hypertension prevalence by countries, Hypertension market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Hypertension pipeline: Find out drugs in clinical trials for Hypertension by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Hypertension epidemiology: Find out number of patients diagnosed (prevalence) with Hypertension by countries
– Hypertension drugs: Identify key drugs marketed and prescribed for Hypertension by countries, including trade name, molecule name, and company
– Hypertension drugs sales: Find out the sales value for Hypertension drugs by countries
– Hypertension market valuations: Find out the market size for Hypertension drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Hypertension drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Hypertension drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Hypertension market
– Develop in-depth knowledge of competition and markets
– Analyze Hypertension drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Hypertension market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Hypertension Treatment Options
2. Hypertension Pipeline Insights
2.1. Hypertension Phase 3 Clinical Trials
2.2. Hypertension Phase 2 Clinical Trials
2.3. Hypertension Phase 1 Clinical Trials
3. Hypertension Epidemiology Analysis by Countries
4. Germany Hypertension Market Insights
4.1. Marketed Drugs for Hypertension in Germany
4.2. Germany Hypertension Market Size & Forecast
4.3. Germany Hypertension Drugs Sales Forecast
4.4. Germany Hypertension Market Share Analysis
5. France Hypertension Market Insights
5.1. Marketed Drugs for Hypertension in France
5.2. France Hypertension Market Size & Forecast
5.3. France Hypertension Product Sales Forecast
5.4. France Hypertension Market Share Analysis
6. Italy Hypertension Market Insights
6.1. Marketed Drugs for Hypertension in Italy
6.2. Italy Hypertension Market Size & Forecast
6.3. Italy Hypertension Product Sales Forecast
6.4. Italy Hypertension Market Share Analysis
7. Spain Hypertension Market Insights
7.1. Marketed Drugs for Hypertension in Spain
7.2. Spain Hypertension Market Size & Forecast
7.3. Spain Hypertension Product Sales Forecast
7.4. Spain Hypertension Market Share Analysis
8. UK Hypertension Market Insights
8.1. Marketed Drugs for Hypertension in UK
8.2. UK Hypertension Market Size & Forecast
8.3. UK Hypertension Product Sales Forecast
8.4. UK Hypertension Market Share Analysis
9. Europe Hypertension Market Insights
9.1. Europe Hypertension Market Size & Forecast
9.2. Europe Hypertension Product Sales Forecast
9.3. Europe Hypertension Market Share Analysis
10. Research Methodology
List of Tables
1: Hypertension Phase 3 Clinical Trials, Global, 2020
2: Hypertension Phase 2 Clinical Trials, Global, 2020
3: Hypertension Phase 1 Clinical Trials, Global, 2020
4: Hypertension Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Hypertension in Germany, 2019
6: Germany Hypertension Market Size & Forecast ($mn), 2016 – 2025
7: Germany Hypertension Product Sales ($mn), 2016 – 2025
8: Germany Hypertension Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Hypertension in France, 2019
10: France Hypertension Market Size & Forecast ($mn), 2016 – 2025
11: France Hypertension Product Sales ($mn), 2016 – 2025
12: France Hypertension Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Hypertension in Italy, 2019
14: Italy Hypertension Market Size & Forecast ($mn), 2016 – 2025
15: Italy Hypertension Product Sales ($mn), 2016 – 2025
16: Italy Hypertension Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Hypertension in Spain, 2019
18: Spain Hypertension Market Size & Forecast ($mn), 2016 – 2025
19: Spain Hypertension Product Sales ($mn), 2016 – 2025
20: Spain Hypertension Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Hypertension in UK, 2019
22: UK Hypertension Market Size & Forecast ($mn), 2016 – 2025
23: UK Hypertension Product Sales ($mn), 2016 – 2025
24: UK Hypertension Market Events and Trends, 2016 – 2025
25: Europe Hypertension Market Size & Forecast ($mn), 2016 – 2025
26: Europe Hypertension Product Sales ($mn), 2016 – 2025
List of Figures
1: Hypertension Pipeline by Phase (%), Global, 2020
2: Hypertension Prevalence by Countries, 2016 – 2025
3: Germany Hypertension Market Size ($mn), 2016 – 2025
4: Germany Hypertension Product Sales ($mn), 2016 – 2025
5: Germany Hypertension Market Share by Drugs (%), 2019
6: Germany Hypertension Market – Future Market Share (%), 2025
7: France Hypertension Market Size ($mn), 2016 – 2025
8: France Hypertension Product Sales ($mn), 2016 – 2025
9: France Hypertension Market Share by Drugs (%), 2019
10: France Hypertension Market – Future Market Share (%), 2025
11: Italy Hypertension Market Size ($mn), 2016 – 2025
12: Italy Hypertension Product Sales ($mn), 2016 – 2025
13: Italy Hypertension Market Share by Drugs (%), 2019
14: Italy Hypertension Market – Future Market Share (%), 2025
15: Spain Hypertension Market Size ($mn), 2016 – 2025
16: Spain Hypertension Product Sales ($mn), 2016 – 2025
17: Spain Hypertension Market Share by Drugs (%), 2019
18: Spain Hypertension Market – Future Market Share (%), 2025
19: UK Hypertension Market Size ($mn), 2016 – 2025
20: UK Hypertension Product Sales ($mn), 2016 – 2025
21: UK Hypertension Market Share by Drugs (%), 2019
22: UK Hypertension Market – Future Market Share (%), 2025
23: Europe Hypertension Market Size ($mn), 2016 – 2025
24: Europe Hypertension Product Sales ($mn), 2016 – 2025
25: Europe Hypertension Market Share by Drugs (%), 2019
26: Europe Hypertension Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.